Concordance assessment through comparison with urine cotinine: Does self-report adequately reflect passive smoking?
- PMID: 36762264
- PMCID: PMC9900479
- DOI: 10.18332/tid/156458
Concordance assessment through comparison with urine cotinine: Does self-report adequately reflect passive smoking?
Abstract
Introduction: There is a paucity of studies evaluating passive smoking (PS) by comparing self-report (SR) and biomarkers. Our study aimed to confirm whether SR could accurately reflect PS compared to biomarkers, a golden standard for assessing the exposure of non-smokers.
Methods: We used the 2014-2020 Korea National Health and Nutrition Examination Survey data and selected 29622 non-smokers aged >19 years as the study participants. The PS rate by SR was assessed during the last 7 days, and participants were interviewed to investigate their exposure at home, work, indoors, and in public places. In addition, participants having a limit of detection ≥0.5 ng/mL in urine cotinine (UC) was defined as the exposure group. All analyses reflected the weights of complex sampling. We first compared the rates of PS using biomarkers and SR, and then the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated based on biomarkers.
Results: PS exposure by UC was the highest (44.4%), and the exposure by SR was significantly lower (5.1-29.5%). Kappa and sensitivity in PS in the indoor home (HPS) were lower than those in indoor workplaces (WPS) and indoor public places (PPS). Moreover, overall sensitivity and PPV were lower, and specificity and NPV were relatively higher in accuracy. Lastly, the sensitivity was poor, and the specificity was relatively good, which means that measurement by SR would identify people who were actually exposed to PS as non-exposed.
Conclusions: Despite exposure to PS, the use of the SR method is more likely to classify participants in the non-exposed group. Hence, to overcome measurement error in SR and reflect exposure in any place and setting, biomonitoring and SR should be performed.
Keywords: biomarker; limit of detection; passive smoking; self-report; urine cotinine.
© 2023 Park M.B.
Conflict of interest statement
The author has completed and submitted an ICMJE form for disclosure of potential conflicts of interest. The author declares that he has no competing interests, financial or otherwise, related to the current work. M.B. Park reports that since the initial planning of the work, the National Research Foundation of Republic of Korea supported this study.
Figures



Similar articles
-
Urine Cotinine for Assessing Tobacco Smoke Exposure in Korean: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES).Tuberc Respir Dis (Seoul). 2012 Oct;73(4):210-8. doi: 10.4046/trd.2012.73.4.210. Epub 2012 Oct 31. Tuberc Respir Dis (Seoul). 2012. PMID: 23166556 Free PMC article.
-
Exposure to environmental tobacco smoke in non - smoking adults in Israel: results of the second Israel biomonitoring survey.Isr J Health Policy Res. 2018 Jun 25;7(1):33. doi: 10.1186/s13584-018-0229-9. Isr J Health Policy Res. 2018. PMID: 29936912 Free PMC article.
-
Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.Nicotine Tob Res. 2011 Mar;13(3):202-8. doi: 10.1093/ntr/ntq237. Epub 2011 Jan 21. Nicotine Tob Res. 2011. PMID: 21330276 Free PMC article.
-
Validity of Self-Reported Tobacco Smoke Exposure among Non-Smoking Adult Public Housing Residents.PLoS One. 2016 May 12;11(5):e0155024. doi: 10.1371/journal.pone.0155024. eCollection 2016. PLoS One. 2016. PMID: 27171392 Free PMC article.
-
Serum cotinine verification of self-reported smoking status among adults eligible for lung cancer screening in the 1999-2018 National Health and Nutrition Examination Survey.Lung Cancer. 2020 Jun;144:49-56. doi: 10.1016/j.lungcan.2020.04.019. Epub 2020 Apr 23. Lung Cancer. 2020. PMID: 32371260
Cited by
-
Association between perceived exposure to secondhand smoke and depression independent of biomarker-measured exposure.BMC Public Health. 2025 Aug 25;25(1):2917. doi: 10.1186/s12889-025-23967-8. BMC Public Health. 2025. PMID: 40855424 Free PMC article.
References
-
- GBD 2017 Risk Factor Collaborators Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–1994. doi: 10.1016/S0140-6736(18)32225-6. - DOI - PMC - PubMed
-
- Watson R, Zibadi S, editors. Addictive Substances and Neurological Disease. Academic Press; 2017.
LinkOut - more resources
Full Text Sources
Research Materials